Research Library — Page 57 | Reta Compare
3563 research articles. Page 57 of 143.
Articles
- Investigating Retatrutide Pharmacokinetics in Renal Impairment: A Clinical Study Overview
- Exploring the Effects of Retatrutide on Weight Loss in Obesity and Overweight Participants
- Exploring the Safety and Tolerability of Retatrutide in Chinese Participants with Obesity
- Evaluating the Efficacy of Retatrutide in Type 2 Diabetes Management
- Exploring the Drug-Drug Interactions of Retatrutide: Insights from a New Study
- Exploring Retatrutide: Insights from a Study on Japanese Participants with Type 2 Diabetes
- Exploring Retatrutide: Insights from the LY3437943 Study in Type 2 Diabetes
- Exploring the Safety Profile of Retatrutide: Insights from Clinical Trial NCT03841630
- Advancements in Retatrutide Research: Surgical Threshold Crossed
- Retatrutide Achieves Significant Weight Loss Results in Recent Study
- Exploring Retatrutide: A Promising Weight Loss Agent Awaiting Approval
- Exploring Retatrutide: A Distinct Approach to Weight Loss Compared to Ozempic
- Evaluating the Safety Profile of Retatrutide in Comparison to Ozempic
- Exploring Side Effects of Retatrutide: Insights from Four Months of Use
- Comparing Retatrutide and Tirzepatide: Insights for Advanced Research
- Exploring Retatrutide: A New GLP-1 Injection for Metabolic Health
- Exploring Retatrutide: A New Era in GLP-1 Injection Therapy
- Understanding Retatrutide: Insights on Safety and Side Effects
- Exploring the Potential of Retatrutide for Weight Loss and Longevity
- Comparative Insights on Retatrutide for Weight Control Against Tirzepatide
- Understanding How to Access Retatrutide for Research and Clinical Use
- Exploring the Buzz Around Retatrutide: A New Weight-Loss Peptide
- Exploring the Early Results of Retatrutide for Weight Loss in 2026
- Exploring Retatrutide: Insights on Weight Loss and Its Comparison to Other Peptides
- Retatrutide Shows Promising Results in Phase 3 Trial for Type 2 Diabetes Management